Global Health Investment Corporation
500 5th Ave Ste 4000, New York City, NY, 10110, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Aerska | May 2026Led | $10 MSeries A | |
Terrestrial Bio | Mar 2026Participated | $50 MSeries C | |
Prenosis | Feb 2026Participated | $20 MSeries A | |
Antheia | Jan 2026Participated | $24 MSeries C | |
Antheia | Jun 2025Led | $56 MSeries C | |
Micron Biomedical | Jan 2025Led | $16 MSeries A | |
CytoVale | Oct 2024Participated | $100 MSeries D | |
Vaxess Technologies | May 2024Participated | $12 MOther Equity | |
Biolinq | Apr 2024Participated | $58 MOther Equity | |
CytoVale | Nov 2023Participated | $84 MSeries C | |
Vaxess Technologies | Sep 2023Participated | $9 MOther Equity | |
Micron Biomedical | Nov 2022Led | $14 MSeries A | |
Aerska | May 2026Led | $10 MSeries A | |
Terrestrial Bio | Mar 2026Participated | $50 MSeries C | |
Prenosis | Feb 2026Participated | $20 MSeries A | |
Antheia | Jan 2026Participated | $24 MSeries C | |
Antheia | Jun 2025Led | $56 MSeries C | |
Micron Biomedical | Jan 2025Led | $16 MSeries A | |
CytoVale | Oct 2024Participated | $100 MSeries D | |
Vaxess Technologies | May 2024Participated | $12 MOther Equity | |
Biolinq | Apr 2024Participated | $58 MOther Equity | |
CytoVale | Nov 2023Participated | $84 MSeries C | |
Vaxess Technologies | Sep 2023Participated | $9 MOther Equity | |
Micron Biomedical | Nov 2022Led | $14 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 3 | 2 |
| Series B | 0 | 2 |
| Series C+ | 1 | 4 |
| Other Equity | 0 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 2 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 1 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 16 |
| AI & Machine Learning | 3 |
| Hardware & Robotics | 2 |
| Manufacturing | 2 |
| Marketing & Advertising | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 6 |
| $25M-$50M | 2 |
| $50M-$100M | 5 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 15 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| RA Capital Management | 4 |
| Aphelion Capital | 2 |
| ATHOS | 2 |
| AXA IM Alts | 2 |
| Boom Capital | 2 |
| Engine Ventures | 2 |
| Mission BioCapital | 2 |
| Norwest Venture Partners | 2 |
| RiverVest Venture Partners | 2 |
| Sands Capital | 2 |
| Senvest Management | 2 |
| Taisho Pharmaceutical | 2 |
| Alix Ventures | 1 |
| Alpha Wave Global | 1 |
| Alpha Wave Ventures | 1 |
| AME Cloud Ventures | 1 |
| America's Frontier Fund | 1 |
| Ascensia Diabetes Care | 1 |
| Bill & Melinda Gates Foundation | 1 |
| Biolinq | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 25% |
| Participating | 12 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 25% |
| Co-led | 3 | 75% |
Team
Managing Director
Chairman and CEO